Ethical implications of poor comparative effectiveness evidence: obligations in industry-research partnerships.
Which treatment is best for me? This question is at the centre of the clinical consultation. And yet, too often, the question is not answerable with available evidence on drugs and devices. The two Lancet Series papers on comparative effectiveness 1 , 2 document the shortcomings of the process for...
Main Authors: | , , , , |
---|---|
Format: | Journal article |
Language: | English |
Published: |
Elsevier
2020
|